HUM

Humana Inc. [HUM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HUM Stock Summary

Top 10 Correlated ETFs

HUM


Top 10 Correlated Stocks

HUM


In the News

01:43 29 Sep 2023 HUM

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Humana's adjusted diluted EPS and free cash flow payout ratios make the dividend very secure. The managed care company's revenue and adjusted diluted EPS both surged in the first half of 2023. Humana's interest coverage ratio of over 13 is part of why it earns investment-grade credit ratings from the major rating agencies.

04:23 29 Sep 2023 HUM

Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains

In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth potential.

11:04 29 Sep 2023 HUM

The 3 Most Undervalued Healthcare Stocks to Buy in September 2023

Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index.

03:02 29 Sep 2023 HUM

Here's Why Investors Should Hold Humana (HUM) in Portfolio

Humana (HUM) remains well-poised for growth on the back of an expanding Medicare Advantage membership, upgraded health plan offering suite and solid cash reserves.

12:02 29 Sep 2023 HUM

Humana (HUM) to Provide In-home Care With Primary Care Anywhere

Humana (HUM) enhances its CenterWell brand with the launch of Primary Care Anywhere.

11:18 29 Sep 2023 HUM

Why Humana (HUM) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

05:26 29 Sep 2023 HUM

A Quality Executive Compensation Plan Lowers The Risk Of Investing In Humana

Humana (HUM) is the featured stock in August's Exec Comp Aligned with ROIC Model Portfolio.

12:47 29 Sep 2023 HUM

5 HMO Stocks to Watch Amid Growing Premiums & Membership

Expanding customer base, contract wins and a rapidly growing aging U.S. population will likely drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry trends.

12:46 29 Sep 2023 HUM

Humana (HUM) to Bring Enhanced Kidney Care to MA Members

Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.

04:15 29 Sep 2023 HUM

Humana Inc. to Present at the Wells Fargo 2023 Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, at 8:00 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately.

HUM Financial details

Company Rating
Buy
Market Cap
61.22B
Income
3.38B
Revenue
98.73B
Book val./share
135.13
Cash/share
252.58
Dividend
4.24
Dividend %
0.86%
Employees
67.1K
Optionable
Yes
Shortable
Yes
Earnings
01 Nov 2023
P/E
18.19
Forward P/E
-
PEG
9.94
P/S
0.62
P/B
3.65
P/C
1.96
P/FCF
5.03
Quick Ratio
1.16
Current Ratio
1.37
Debt / Equity
0.72
LT Debt / Equity
0.58
-
-
EPS (TTM)
26.96
EPS next Y
-
EPS next Q
5.31
EPS this Y
-4.34%
EPS next Y
-
EPS next 5Y
-22.42%
EPS last 5Y
12.24%
Revenue last 5Y
10.29%
Revenue Q/Q
0.02%
EPS Q/Q
-22.3%
-
-
-
-
SMA20
3.15%
SMA50
11.85%
SMA100
-7.53%
Inst Own
92.41%
Inst Trans
0.97%
ROA
6%
ROE
21%
ROC
0.16%
Gross Margin
78%
Oper. Margin
5%
Profit Margin
3%
Payout
12%
Shs Outstand
123.91M
Shs Float
123.61M
-
-
-
-
Target Price
549.89
52W Range
423.29-571.3
52W High
-13.25%
52W Low
+17.11%
RSI
63
Rel Volume
0.47
Avg Volume
1.3M
Volume
613.47K
Perf Week
2.18%
Perf Month
1.35%
Perf Quarter
-5.57%
Perf Half Y
-2.29%
-
-
-
-
Beta
0.662863
-
-
Volatility
2.59%, 11.16%
Prev Close
0.36%
Price
495.36
Change
0.5%

HUM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
413.95484.04583.63645.47721.67
Net income per share
12.2420.1925.4722.7921.8
Operating cash flow per share
15.8139.4242.6617.5835.64
Free cash flow per share
11.3533.9335.367.3526.94
Cash per share
89.97112.09130.31128.89147.19
Book value per share
73.9189.79103.84124.95118.98
Tangible book value per share
43.7859.1767.7218.4334.68
Share holders equity per share
73.9189.79103.84124.95118.98
Interest debt per share
46.9745.7554.94102.1591.89
Market cap
39.39B49.13B54.24B59.69B65.91B
Enterprise value
43.28B50.97B56.54B69.12B72.28B
P/E ratio
23.418.1516.1120.3523.49
Price to sales ratio
0.690.760.70.720.71
POCF ratio
18.139.39.6226.3914.37
PFCF ratio
25.2310.811.663.119.01
P/B Ratio
3.884.083.953.714.3
PTB ratio
3.884.083.953.714.3
EV to sales
0.760.790.730.830.78
Enterprise value over EBITDA
15.3212.610.6916.7315.01
EV to operating cash flow
19.929.6510.0330.5615.76
EV to free cash flow
27.7311.2112.173.0620.85
Earnings yield
0.040.060.060.050.04
Free cash flow yield
0.040.090.090.020.05
Debt to equity
0.610.490.510.80.75
Debt to assets
0.250.20.20.290.27
Net debt to EBITDA
1.380.450.442.281.32
Current ratio
1.341.481.41.221.52
Interest coverage
10.5114.3416.5210.489.9
Income quality
1.291.951.670.771.64
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.160.110.10.120.14
Sales general and administrative to revenue
0.130000
Research and developement to revenue
00000
Intangibles to total assets
0.160.140.130.250.21
Capex to operating cash flow
-0.28-0.14-0.17-0.58-0.24
Capex to revenue
-0.01-0.01-0.01-0.02-0.01
Capex to depreciation
-1.15-1.28-1.56-1.85-1.33
Stock based compensation to revenue
00000
Graham number
142.67201.98243.94253.14241.6
ROIC
0.110.150.160.10.12
Return on tangible assets
0.080.110.110.090.08
Graham Net
-28.39-23.29-43.86-105.22-58.18
Working capital
3.37B5.19B5.29B3.33B9.01B
Tangible asset value
6.02B8.11B9.28B5.01B6.23B
Net current asset value
-1.87B-955M-2.88B-9.84B-1.5B
Invested capital
0.610.490.510.80.75
Average receivables
934.5M1.04B1.1B1.48B1.74B
Average payables
9.9B9.06B11.06B12.48B13.65B
Average inventory
-1.78B-3.69B-4.54B-5.88B-3.25B
Days sales outstanding
6.515.945.387.976.58
Days payables outstanding
395.22492.73441.4461.43417.74
Days of inventory on hand
-172.87-188.21-191.58-234.160
Receivables turnover
56.0761.4567.845.7955.48
Payables turnover
0.920.740.830.790.87
Inventory turnover
-2.11-1.94-1.91-1.560
ROE
0.170.220.250.180.18
Capex per share
-4.45-5.49-7.29-10.23-8.7

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
187.02180.13178.59213.93214.71
Net income per share
5.59.44-0.19.917.7
Operating cash flow per share
7.5866.78-40.8153.4925.49
Free cash flow per share
5.3764.51-42.8651.7123.38
Cash per share
143.77210.8150.76229.33252.58
Book value per share
122.43128.42121.86132.61135.13
Tangible book value per share
31.4342.8535.5258.5159.02
Share holders equity per share
122.43128.42121.86132.61135.13
Interest debt per share
105.386.491.7897.0398.91
Market cap
59.22B61.41B64.35B60.68B55.7B
Enterprise value
67.29B58.69B70.72B58.97B51.69B
P/E ratio
21.2712.85-1.24K12.2414.52
Price to sales ratio
2.52.692.872.272.08
POCF ratio
61.757.27-12.559.0817.54
PFCF ratio
87.097.52-11.959.3919.13
P/B Ratio
3.823.784.23.663.31
PTB ratio
3.823.784.23.663.31
EV to sales
2.842.573.152.21.93
Enterprise value over EBITDA
46.9636.27280.6231.0833.01
EV to operating cash flow
70.176.94-13.798.8216.27
EV to free cash flow
98.967.19-13.139.1217.75
Earnings yield
0.010.0200.020.02
Free cash flow yield
0.010.13-0.080.110.05
Debt to equity
0.850.670.750.720.72
Debt to assets
0.280.210.270.220.22
Net debt to EBITDA
5.63-1.6825.25-0.91-2.56
Current ratio
1.571.491.521.391.37
Interest coverage
12.1213.760.3214.8611.97
Income quality
1.387.09284.835.43.32
Dividend Yield
00000
Payout ratio
0.140.08-7.770.080.12
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.250.210.210.170.17
Capex to operating cash flow
-0.29-0.030.05-0.03-0.08
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-1.33-1.35-1.19-1.02-1.17
Stock based compensation to revenue
00000
Graham number
123.1165.1616.84171.97152.99
ROIC
0.030.0500.050.04
Return on tangible assets
0.020.0300.030.02
Graham Net
-83.73-125.08-59.59-57.16-56.41
Working capital
9.85B9.25B9.01B10.59B10.48B
Tangible asset value
3.98B5.42B6.23B7.31B7.35B
Net current asset value
-4.09B-6.16B-1.5B-610M-805M
Invested capital
0.850.670.750.720.72
Average receivables
3.27B2.49B1.64B2.39B2.27B
Average payables
15.34B15.72B15.25B15.98B17.94B
Average inventory
-2.86B-9.27B-9.27B00
Days sales outstanding
12.816.356.7110.464.81
Days payables outstanding
437.86470.52103.01527.16532.94
Days of inventory on hand
0-545.23000
Receivables turnover
7.0214.1713.48.6118.72
Payables turnover
0.210.190.870.170.17
Inventory turnover
0-0.17000
ROE
0.040.0700.070.06
Capex per share
-2.21-2.28-2.05-1.78-2.12

HUM Frequently Asked Questions

What is Humana Inc. stock symbol ?

Humana Inc. is a US stock , located in Louisville of Ky and trading under the symbol HUM

Is Humana Inc. buy or a sell ?

34 stock analysts have 34 predictions with a medium analyst target price of $533.21. The lowest prediction is $450 and the highest is $652

What is HUM stock prediction ?

What is Humana Inc. stock quote today ?

Humana Inc. stock price is $495.36 today.

Is Humana Inc. stock public?

Yes, Humana Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap